Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Dell Children's Medical center
mi
from
Austin, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Dell Children's Medical center
mi
from
Austin, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Center for Urologic Care
mi
from
Voorhees, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Center for Urologic Care
mi
from
Voorhees, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Delaware Valley Urology LLC
mi
from
Mount Holly, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Delaware Valley Urology LLC
mi
from
Mount Holly, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Group of New Mexico
mi
from
Albuquerque, NM
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Group of New Mexico
mi
from
Albuquerque, NM
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
The Urological Institute of NE NY, CCP
mi
from
Albany, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
The Urological Institute of NE NY, CCP
mi
from
Albany, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Medical & Clinical Research Associates
mi
from
Bay Shore, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Medical & Clinical Research Associates
mi
from
Bay Shore, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Brooklyn Heights Urology Associates, P.C.
mi
from
Brooklyn, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Brooklyn Heights Urology Associates, P.C.
mi
from
Brooklyn, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
University Urology Associates
mi
from
, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
University Urology Associates
mi
from
, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Hudson Valley Urology
mi
from
Poughkeepsie, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Hudson Valley Urology
mi
from
Poughkeepsie, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Staten Island Urology Oncology
mi
from
Staten Island, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Staten Island Urology Oncology
mi
from
Staten Island, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Northeast Urology Research
mi
from
Concord, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Northeast Urology Research
mi
from
Concord, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Alliance Urology Specialists
mi
from
Greensboro, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Alliance Urology Specialists
mi
from
Greensboro, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Parkhurst Research Organization, LLC
mi
from
Bethany, OK
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Parkhurst Research Organization, LLC
mi
from
Bethany, OK
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urological Associates of Lancaster
mi
from
Lancaster, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urological Associates of Lancaster
mi
from
Lancaster, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
State College Urologic Association
mi
from
State College, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
State College Urologic Association
mi
from
State College, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
VA Medical Center, Lexington
mi
from
Lexington, KY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
VA Medical Center, Lexington
mi
from
Lexington, KY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Associates
mi
from
Nashville, TN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Associates
mi
from
Nashville, TN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Associates of North Texas
mi
from
Arlington, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Associates of North Texas
mi
from
Arlington, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Nationsmed Clinical Research
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Nationsmed Clinical Research
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Mobley Clinical Research Center
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Mobley Clinical Research Center
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Fletcher Allen Health Care
mi
from
Burlington, VT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Fletcher Allen Health Care
mi
from
Burlington, VT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology of Virginia
mi
from
Norfolk, VA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology of Virginia
mi
from
Norfolk, VA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Virginal Urology
mi
from
Richmond, VA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Virginal Urology
mi
from
Richmond, VA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Seattle Urology Research Center
mi
from
Seattle, WA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Seattle Urology Research Center
mi
from
Seattle, WA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Roger D. Fincher, PS
mi
from
Spokane, WA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Roger D. Fincher, PS
mi
from
Spokane, WA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Children's Hospital
mi
from
Pittsburgh, PA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Children's Hospital
mi
from
Pittsburgh, PA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Children's Hospital - Boston
mi
from
Boston, MA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Children's Hospital - Boston
mi
from
Boston, MA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Siteman Cancer Center
mi
from
St. Louis, MO
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Siteman Cancer Center
mi
from
St. Louis, MO
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Children's Hospital at Downstate
mi
from
Brooklyn, NY
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Children's Hospital at Downstate
mi
from
Brooklyn, NY
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Children's Hospital of Pittsburgh - University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Children's Hospital of Pittsburgh - University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
St. Jude Childrens Research Hosp, Memphis
mi
from
Memphis, TN
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
St. Jude Childrens Research Hosp, Memphis
mi
from
Memphis, TN
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Baylor School of Medicine
mi
from
Houston, TX
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Randomized Phase II Study of Omega-3-Fatty Acid on Joint Symptoms Induced by Aromatase Inhibitors in Breast Cancer Patients
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Randomized Phase II Study of Omega-3-Fatty Acid on Joint Symptoms Induced by Aromatase Inhibitors in Breast Cancer Patients
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
DB-67 in Myelodysplastic Syndrome (MDS)
Phase II Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
Status: Archived
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
DB-67 in Myelodysplastic Syndrome (MDS)
Phase II Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
A Phase 2 Study of EZN-2208 (PEG-SN38) Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma (mCRC)
Status: Archived
Clinical Research Facility
mi
from
Tucson, AZ
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
A Phase 2 Study of EZN-2208 (PEG-SN38) Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma (mCRC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Tucson, AZ
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
A Phase 2 Study of EZN-2208 (PEG-SN38) Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma (mCRC)
Status: Archived
Clinical Research Facility
mi
from
Alhambra, CA
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
A Phase 2 Study of EZN-2208 (PEG-SN38) Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma (mCRC)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Alhambra, CA